Literature DB >> 27478583

Huge Aneurysm of the Proper Hepatic Artery.

Mohamed Amine Attaoui1, Rached Bayar2, Zeineb Mzoughi2, Sahir Omrani2, Lassaad Gharbi2, Mohamed Taher Khalfallah2.   

Abstract

Hepatic artery aneurysms are rarely diagnosed. It is mainly because of non specific symptoms. They are generally an incidental findings during imaging studies. They are usually detected in the sixth decade, predominantly in men. We report herein a case of an 80 year-old man with a huge hepatic artery aneurysm revealed by abdominal pain and chronic anemia. It was treated by embolisation. Hepatic artery aneurysms are second among visceral aneurysms. They may cause abdominal pain, jaundice and hemorrhagic events.

Entities:  

Keywords:  Aneurysm; embolization; hepatic artery

Year:  2016        PMID: 27478583      PMCID: PMC4943103          DOI: 10.4081/cp.2016.846

Source DB:  PubMed          Journal:  Clin Pract        ISSN: 2039-7275


Introduction

Hepatic artery aneurysms (HAAs) are rare, representing about 0.01-2% of all arterial aneurysms.[1] They are the second most common aneurysm of the splanchnic system after splenic artery aneurysms.[2] The rupture of hepatic artery aneurysms is seen in more than 80% of patients. Mortality is approaching 40% for the surgical treatment.[3]

Case Report

An 80-year old men who had a medical history of arterial hypertension, was admitted for gastro intestinal bleeding and anemia. The hemoglobin rate was 4 g/dL, liver blood tests were normal. Physical examination showed an upper right abdominal tenderness. Upper endoscopy and colonoscopy showed no abnormality. Abdominal ultrasonography with arterial Doppler revealed a 6 cm well surrounded mass of the liver with a color flow. A thrombosed aneurysm was evocated. The computed tomography showed a giant (62 mm) hepatic artery aneurysm, which compressed the pancreatic duct (Figure 1). No hemoperitoneum was seen. The patient underwent a successful embolization of the aneurysm (Figure 2). The outcomes were uneventful with normal liver blood tests. He was seen one year after and he continued to do well with normal liver function and no recanalization of the aneurysm in abdominal computed tomography (CT) scan control.
Figure 1.

Computed tomography angiography with three-dimensional reconstruction showing an aneurysm of proper hepatic artery.

Figure 2.

Computed tomography scan after embolization showing coils into hepatic artery.

Discussion

HAAs can occur in the common, proper, left or right hepatic arteries. The incidence is estimated to be between 0.002 and 0.4%.[4] The diagnosis is difficult at first, because the symptoms are not specific. HAA can be revealed by pain, jaundice and hemorrhagic symptoms. Rupture can be intraperitoneal, into the biliary tree or into the gastro intestinal tract. Unlike aortic aneurysm, the correlation between the size and the possibility of rupture is still unknown. It is reported that all lesions warrant treatment.[5] On ultrasonography, the aneurysm appears as an anechoic mass or a complex mass with an anechoic center located often at the porta hepatis. The abdominal CT, the magnetic resonance imaging and the mesenteric angiography can have more accuracy.[6] In our case, the diagnosis was suspected on ultrasonography and confirmed by the abdominal CT. Therapeutic options include the embolization of the aneurysm, the stenting across the parent vessel, the embolization of the common hepatic artery or a surgical repair with or without reconstruction. Endoscopic treatment represents an alternative with good results and a lower mortality and morbidity rate.[7] The incidence of hepatic necrosis following the interruption of the common hepatic artery is low, owing to a rich hepatic collateral supply.[8] The percutaneous embolization has a particular value in intrahepatic aneurysms and in high risk patients. This treatment option was chosen, in our case, regarding to the age of the patient, the comorbidities (hypertension) and the profound anemia. The hepatic aneurysm was intrahepatically located. Regular follow up is recommended as recanalization may occur.

Conclusions

HAAs should be diagnosed before rupture. Abdominal pain, bleeding or compression may be the first symptoms.
  8 in total

Review 1.  Ruptured hepatic artery aneurysm: case report and review of literature.

Authors:  Matthew A Arneson; R Stephen Smith
Journal:  Ann Vasc Surg       Date:  2005-07       Impact factor: 1.466

2.  Visceral artery aneurysms.

Authors:  R Chiesa; D Astore; G Guzzo; S Frigerio; Y Tshomba; R Castellano; M R Liberato de Moura; G Melissano
Journal:  Ann Vasc Surg       Date:  2005-01       Impact factor: 1.466

Review 3.  Hepatic and splenic artery aneurysms.

Authors:  Scott A Berceli
Journal:  Semin Vasc Surg       Date:  2005-12       Impact factor: 1.000

4.  Treatment of visceral artery aneurysms: description of a retrospective series of 42 aneurysms in 34 patients.

Authors:  Carmine Sessa; Giovanni Tinelli; Paolo Porcu; Axel Aubert; Frederic Thony; Jean-Luc Magne
Journal:  Ann Vasc Surg       Date:  2004-11       Impact factor: 1.466

5.  Multiple hepatic artery aneurysms: use of transcatheter embolization for rupture.

Authors:  Paul J Riesenman; Thomas C Bower; Gustavo S Oderich; Haraldur Bjarnason
Journal:  Ann Vasc Surg       Date:  2006-04-26       Impact factor: 1.466

6.  Hemorrhage from a right hepatic artery pseudoaneurysm: endovascular treatment with a coronary stent-graft.

Authors:  Massimo Venturini; Enzo Angeli; Marco Salvioni; Francesco De Cobelli; Chiara Trentin; Michele Carlucci; Carlo Staudacher; Alessandro Del Maschio
Journal:  J Endovasc Ther       Date:  2002-04       Impact factor: 3.487

7.  Endovascular treatment of a hepatic artery aneurysm causing chronic abdominal pain; a case report.

Authors:  Gabrielle L de Ruiter-Derksen; Rutger C G Bruijnen; Frank Joosten; Michel M P J Reijnen
Journal:  Ann Hepatol       Date:  2010 Jan-Mar       Impact factor: 2.400

8.  Hepatic artery aneurysm: factors that predict complications.

Authors:  Maher A Abbas; Richard J Fowl; William M Stone; Jean M Panneton; W Andrew Oldenburg; Thomas C Bower; Kenneth J Cherry; Peter Gloviczki
Journal:  J Vasc Surg       Date:  2003-07       Impact factor: 4.268

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.